CD70 antibody (N-Term)
Quick Overview for CD70 antibody (N-Term) (ABIN2774311)
Target
See all CD70 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- VICLVVCIQR FAQAQQQLPL ESLGWDVAEL QLNHTGPQQD PRLYWQGGPA
-
Predicted Reactivity
- Cow: 85%, Guinea Pig: 85%, Horse: 77%, Human: 100%, Rabbit: 85%
-
Characteristics
- This is a rabbit polyclonal antibody against CD70. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 193 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- CD70 (CD70 Molecule (CD70))
-
Alternative Name
- CD70
-
Background
-
The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF27/CD27. It is a surface antigen on activated, but not on resting, T and B lymphocytes. It induces proliferation of costimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. This cytokine is also reported to play a role in regulating B-cell activation, cytotoxic function of natural killer cells, and immunoglobulin sythesis.
Alias Symbols: CD27L, CD27LG, TNFSF7
Protein Interaction Partner: UBC, CD27, ELAVL1,
Protein Size: 193 -
Molecular Weight
- 21 kDa
-
Gene ID
- 970
-
NCBI Accession
- NM_001252, NP_001243
-
UniProt
- P32970
-
Pathways
- Cancer Immune Checkpoints
Target
-